Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.0175    0.00 (0.00%)
Bid:
0.015
Ask:
0.02
Spread: 0.005 (33.333%)
Market Cap: £1.64m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

HALF-YEARLY REPORT 2026

4 Jun 2026 09:46

RNS Number : 0167H
Sunrise Resources Plc
04 June 2026
 

("Sunrise" or the "Company")

4 June 2026

HALF-YEARLY REPORT 2026

 

 

Sunrise Resources plc is pleased to announce its unaudited interim results for the six months ended 31 March 2026.

 

A copy of this report is also available on the Company's website, www.sunriseresourcesplc.com.

 

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

AlbR Capital Limited

Broker

Lucy Williams/Duncan Vasey

Tel: +44 (0)207 469 0930

 

 

CAUTIONARY NOTICE

The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and, save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.

 

MARKET ABUSE REGULATION (MAR) DISCLOSURE

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

NOMINATED ADVISER

Beaumont Cornish Limited ('Beaumont Cornish') is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

 

 

Chairman's Statement

 

I am pleased to present our unaudited interim results for the six months ended 31 March 2026 and to provide an update on the Company's progress since the release of our 2025 Annual Report.

 

Operational & Corporate Developments

 

As is customary for the Company, in our 2025 Annual Report we covered operational developments up to the date of its publication in mid-February 2026. With so little time elapsed since then, there are no significant project developments to report at this time, although work is ongoing on a number of the Company's projects as set out in the Annual Report.

 

Our Annual General Meeting, held on 25 March 2026, was well supported and all proposed resolutions were passed with over 50% of the issued capital voted and between 92% and 98% of the votes cast in favour. Your Board is grateful for this support.

 

The Company relies upon periodic capital fundraisings until such time as cashflow can be derived either from the sale of assets or future operations. No new funding arrangements were made during the six-month reporting period. However, since the AGM, the Company has taken a number of steps to put the Company on a better financial footing.

 

In April 2026, the Company announced that it had raised £225,000 before expenses through a placing of new ordinary shares. This was achieved at market price, despite a prevailing environment of heavily discounted placings. The placing attracted institutional support and nearly half of this amount was invested by myself and my fellow directors.

 

In line with previous commitments to give existing shareholders an opportunity to participate in share issues, without recourse to an expensive rights issue, the Company also offered new shares for sale to existing shareholders having accounts with the main share dealing platforms on the same terms as the April placing. This offer was made through the Winterflood Retail Access Platform (WRAP) and was 97% subscribed, raising a further £48,467.61 before expenses.

 

The proceeds of these fundraisings have been applied to repay a number of longer-term creditors, most notably to make the final payment to Towards Net Zero, LLC in connection with its historical convertible note financing which, as a result, is now behind us. Other creditors were settled through share issues. In total 468,860,760 new Ordinary Shares were issued concurrent with, and on the same terms as, the April placing and, as a result, we welcome Tertiary Minerals plc as new significant shareholder. Tertiary Minerals plc provides management services at cost to the Company on a cost sharing basis.

 

Financial Results

 

During the six-month period ended 31 March 2026, the Company made a loss of £147,728 after income of £9,338, administration costs of £154,794 and expensed pre-licence exploration costs totalling £2,272.

 

Project expenditure, including foreign exchange movements, amounted to £53,522 for the six-month period to 31 March 2026. As at 31 March 2026, prior to the above-mentioned fundraising, the Company held £30,351 in cash and cash equivalents and liquid listed investments having a value of £3,476. 

 

Looking Ahead

 

The Company rightly considers the fully permitted CS Natural Pozzolan Project and the Pioche Sepiolite Project in the USA to be the Company's most valuable assets and is committed to continuing its pursuit of suitable industry partners to join in the development of these projects. This strategy relies on third party decisions being made, mainly by large, often privately owned, industrial minerals companies whose pace of commitment to green cement and other raw material initiatives, and so decision making, does not match the Board's ambition - or shareholder expectations, particularly in the face of global headwinds and the policies of the current US Administration. This is exemplified by the Hazen Pozzolan Project where an option agreement was signed with a large materials company in July 2025, nearly three years after a 200-ton sample was first sent to that company.

 

Your Board continues to invest in the Company as the directors believe in the underlying value of the Company's assets. We ask our shareholders for further patience, but in the meantime your Board is considering alternative and supplemental strategies where the Company can better control the pace of developments and news flow. We hope to be able to say more about this in due course.

 

On behalf of the Board, I extend our sincere gratitude to our shareholders for their continued support.

 

Sincerely,

 

 

 

 

Patrick Cheetham

Executive Chairman

4 June 2026

 

 

Consolidated Income Statement

for the six months to 31 March 2026

 

 

 

Six months

to 31 March

2026

Unaudited

 

Six months

to 31 March

2025

Unaudited

 

 

Twelve months

to 30 September

2025

Audited

 

£

£

£

Revenue

-

-

-

Cost of sales

-

-

-

Gross profit

-

-

-

 

Other income

9,338

1,968

25,398

Pre-licence exploration costs

(2,272)

(1,443)

(1,300)

Impairment of deferred exploration assets

-

(3,663)

-

Administration costs

(154,794)

(144,781)

(366,348)

Operating loss

(147,728)

(147,919)

(342,250)

 

Interest receivable

-

17

19

 

Loss before income tax

(147,728)

(147,902)

(342,231)

 

Income tax

-

-

-

 

Loss for the period attributable to equity

 

holders of the parent

(147,728)

(147,902)

(342,231)

 

 

 

Loss per share - basic and fully diluted (pence) (Note 2)

(0.002)

(0.003)

(0.006)

 

 

 

Consolidated Statement of Comprehensive Income

for the six months to 31 March 2026

 

 

 

 

 

 

Six months

to 31 March

2026

Unaudited

 

Six months

to 31 March

2025

Unaudited

 

 

Twelve months

to 30 September

2025

Audited

£

£

£

 

Loss for the period

(147,728)

(147,902)

(342,231)

 

Other comprehensive income:

-

-

-

 

 

Items that could be reclassified subsequently to the Income Statement:

 

 

Foreign exchange translation differences on

 

foreign currency net investments in subsidiaries

31,315

62,808

(6,396)

 

Items that will not be reclassified to the Income Statement:

 

 

Changes in the fair value of equity investments

3,319

(2,095)

(2,641)

 

34,634

60,713

(9,037)

 

Total comprehensive loss for the period

 

attributable to equity holders of the parent

(113,094)

(87,189)

(351,268)

 

 

 

Consolidated Statement of Financial Position

as at 31 March 2026

 

 

 

As at

31 March

2026

Unaudited

 

 

As at

31 March

2025

Unaudited

 

 

As at

30 September

2025

Audited

 

£

 

£

£

 

Non-current assets

 

Intangible assets

1,959,512

1,905,562

1,905,990

Other investments

3,476

6,329

1,065

 

1,962,988

1,911,891

1,907,055

 

 

Current assets

 

Receivables

84,330

90,058

83,916

Cash and cash equivalents

30,351

91,730

85,087

114,681

181,788

169,003

 

Current liabilities

 

Trade and other payables

(286,160)

(165,792)

(171,840)

Convertible loan note

(64,000)

(123,000)

(64,000)

(350,160)

(288,792)

(235,840)

 

Net current liabilities

(235,479)

(107,004)

(66,837)

 

Non-current liabilities

 

Provisions for liabilities and charges

(22,978)

(25,384)

(22,593)

(22,978)

(25,384)

(22,593)

 

Net assets

1,704,531

1,779,503

1,817,625

 

 

Equity

 

Called up share capital

78,125

55,330

78,125

Share premium account

6,359,708

6,080,302

6,359,708

Capital redemption reserve

4,054,102

4,054,102

4,054,102

Share warrant reserve

16,090

43,757

16,090

Fair value reserve

(10,158)

(1,375)

(13,477)

Foreign currency reserve

12,049

49,938

(19,266)

Accumulated losses

(8,805,385)

(8,502,551)

(8,657,657)

 

 

Equity attributable to owners of the parent

1,704,531

1,779,503

1,817,625

 

 

 

Consolidated Statement of Changes in Equity

 

 

 

Share

capital

 

Share

premium

account

 

Capital

redemption reserve

 

Share

warrant reserve

 

Fair

value

reserve

 

Foreign

currency

reserve

 

 

Accumulated

losses

 

 

 

Total

 

£

£

£

£

£

£

£

£

At 30 September 2024

49,450

5,995,112

4,054,102

43,757

720

(12,870)

(8,354,649)

1,775,622

Loss for the period

-

-

-

-

-

-

(147,902)

(147,902)

Change in fair value

-

-

-

-

(2,095)

-

-

(2,095)

Exchange differences

-

-

-

-

-

62,808

-

62,808

Total comprehensive loss for

 

 

 

 

the period

-

-

-

-

(2,095)

62,808

(147,902)

(87,189)

Share issue

5,880

85,190

-

-

-

-

-

91,070

Capital redemption reserve

-

-

-

-

-

-

-

-

Share based payments expense

-

-

-

-

-

-

-

-

Transfer of expired warrants

-

-

-

-

-

-

-

-

At 31 March 2025

55,330

6,080,302

4,054,102

43,757

(1,375)

49,938

(8,502,551)

1,779,503

Loss for the period

-

-

-

-

-

-

(155,106)

(155,106)

Change in fair value

-

-

-

-

-

-

-

-

Equity investment disposal reclassification

-

-

-

-

(11,556)

-

-

(11,556)

Exchange differences

-

-

-

-

(546)

(69,204)

-

(69,750)

Total comprehensive loss for

 

 

 

the period

-

-

-

-

(12,102)

(69,204)

(155,106)

(236,412)

Share issue

22,795

279,406

-

-

-

-

-

302,201

Share based payments expense

-

-

-

-

-

-

-

-

Transfer of expired warrants

-

-

-

(27,667)

-

-

-

(27,667)

At 30 September 2025

78,125

6,359,708

4,054,102

16,090

(13,477)

(19,266)

(8,657,657)

1,817,625

Loss for the period

-

-

-

-

-

-

(147,728)

(147,728)

Change in fair value

-

-

-

-

3,529

-

-

3,529

Exchange differences

-

-

-

-

(210)

31,315

-

31,105

Total comprehensive loss for

the period

-

-

-

-

3,319

31,315

(147,728)

(113,094)

At 31 March 2026

78,125

6,359,708

4,054,102

16,090

(10,158)

12,049

(8,805,385)

1,704,531

Consolidated Statement of Cash Flows

for the six months to 31 March 2026

 

 

Six months

to 31 March

2026

Unaudited

Six months

to 31 March

2025

Unaudited

 

Twelve months

to 30

September

2025

Audited

 

£

£

£

Operating activity

 

Operating loss

(147,728)

(147,919)

(342,231)

Shares issued in lieu of net wages

2,352

19,069

19,069

Reclamation provision

(385)

-

1,794

Interest Income

-

-

(19)

(Increase)/decrease in receivables

(284)

89,755

95,897

Increase in trade and other payables

114,320

37,905

43,953

Net cash outflow from operating activity

(31,725)

(1,190)

(181,537)

 

Investing activity

 

 

Interest received

-

17

19

Disposal of equity investments

-

-

5,719

Project development expenditures

(21,044)

(5,494)

(82,308)

Net cash outflow from investing activity

(21,044)

(5,477)

(76,570)

 

Financing activity

 

 

 

Issue of share capital (net of expenses)

-

-

243,200

Net cash inflow from financing activity

-

-

243,200

 

Net decrease in cash and cash equivalents

(52,769)

(6,667)

(14,907)

 

Cash and cash equivalents at start of period

85,087

102,425

102,425

Exchange differences

(1,967)

(4,028)

(2,431)

Cash and cash equivalents at end of period

30,351

91,730

85,087

 

Notes to the Interim Statement

 

1. Basis of preparation

 

The consolidated interim financial information has been prepared in accordance with the accounting policies that are expected to be adopted in the Group's full financial statements for the year ending 30 September 2026 which are not expected to be significantly different to those set out in Note 1 of the Group's audited financial statements for the year ended 30 September 2025. These are based on the recognition and measurement requirements of applicable law and UK adopted International Accounting Standards. The financial information has not been prepared (and is not required to be prepared) in accordance with IAS 34. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of this financial information.

 

The financial information in this statement relating to the six months ended 31 March 2026 and the six months ended 31 March 2025 has neither been audited nor reviewed by the Independent Auditor pursuant to guidance issued by the Auditing Practices Board. The financial information presented for the year ended 30 September 2025 does not constitute the full statutory accounts for that period. The Annual Report and Financial Statements for the year ended 30 September 2025 have been filed with the Registrar of Companies. The Independent Auditor's Report on the Annual Report and Financial Statements for the year ended 30 September 2025 was unqualified, although it did draw attention to matters by way of emphasis in relation to going concern.

 

The directors prepare annual budgets and cash flow projections for a 15-month period. These projections include the proceeds of future fundraising necessary within the period to meet the Company's and the Group's planned discretionary project expenditures and to maintain the Company and the Group as a going concern. Although the Company has been successful in raising finance in the past, there is no assurance that it will obtain adequate finance in the future. These factors represent a material uncertainty related to events or conditions which may cast significant doubt on the entity's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business. However, the directors have a reasonable expectation that they will secure additional funding when required to continue meeting corporate overheads and exploration costs for the foreseeable future and therefore believe that the going concern basis is appropriate for the preparation of the financial statements.

 

 

2. Loss per share

 

Loss per share has been calculated on the attributable loss for the period and the weighted average number of shares in issue during the period.

 

 

Six months

to 31 March

2026

Unaudited

 

 

Six months

to 31 March

2025

Unaudited

 

 

Twelve months

to 30 September

2025

Audited

 

 

 

Loss for the period (£)

(147,728)

(147,902)

(342,231)

 

Weighted average shares in issue (No.)

7,812,401,836

5,182,977,424

5,602,528,609

 

Basic and diluted loss per share (pence)

(0.002)

(0.003)

(0.006)

 

The loss attributable to ordinary shareholders and weighted average number of shares for the purpose of calculating the diluted earnings per share are identical to those used for the basic earnings per share. This is because the exercise of share warrants would have the effect of reducing the loss per share and is therefore not dilutive under the terms of IAS33.

 

 

3. Share capital

 

No share issues took place during the six months to 31 March 2026.

 

Since the end of the reporting period, and as announced on 13 April 2026, 1,562,731,200 new Ordinary Shares were issued at a price of 0.025 pence per share by way of a placing, a retails offer and in part-settlement of outstanding liabilities, and 25,000,000 one-year broker warrants were issued to AlbR Capital Limited as part of the placing, exercisable at the placing price.

 

As announced on 6 May 2026, 45,000,000 five-year warrants were issued to certain officers and non-executive directors of the Company and employees of Tertiary Minerals plc, exercisable at a price of 0.025 pence per share.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FIMPTMTIMMBF
Date   Source Headline
29th Jun 20237:00 amRNSReese Ridge Project Update
12th Jun 20237:00 amRNSPioche Project Update
8th Jun 202312:16 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
5th Jun 20237:00 amRNSAdditional £200,000 Investment
31st May 202311:46 amRNSHalf-year Report
23rd May 20237:00 amRNSNatural Pozzolan Association Symposium
4th May 20233:34 pmRNSTotal Voting Rights
26th Apr 20237:00 amRNSPioche Project Update
14th Apr 202311:52 amRNSHolding(s) in Company
6th Apr 202312:38 pmRNSIssue of Equity & TVR
24th Mar 20237:00 amRNSISSUE OF WARRANTS
15th Mar 20237:00 amRNSNEW MINING CLAIMS: REESE RIDGE PROJECT
17th Feb 202311:57 amRNSResult of AGM
17th Feb 20237:00 amRNSAGM Chairman’s Statement
17th Jan 20239:19 amRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
9th Jan 20237:00 amRNSPioche claims update
22nd Dec 20227:00 amRNSAnnual Report and Notice of AGM
21st Dec 20227:00 amRNSTolsa maintain option to acquire Sepiolite Project
13th Dec 20229:23 amRNSAudited Results for the year to 30 September 2022
7th Dec 20221:54 pmRNSIssue of Convertible Security
30th Nov 20227:00 amRNS£480,000 Investment, Issue of Equity & TVR
22nd Nov 202211:55 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSUpdate - Pioche Sepiolite Project
12th Oct 20227:00 amRNSBulk Sampling - Hazen Pozzolan Project, Nevada
2nd Sep 20227:00 amRNSUpdate - Pioche Sepiolite Project
31st Aug 20224:30 pmRNSTotal Voting Rights
9th Aug 20222:36 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY, WARRANTS & TVR
12th Jul 202212:25 pmRNSPlacing and TVR
28th Jun 20227:00 amRNSSale Option Agreement – Pioche Sepiolite Project
27th Jun 20222:00 pmRNSCS PROJECT – CALTRANS APPROVAL TO AUTHORIZED LIST
24th May 20222:00 pmRNSHALF-YEARLY REPORT 2022
19th May 20227:00 amRNSUPDATE ON MYRTLE GOLD-SILVER PROJECT
11th May 20227:00 amRNSCS PROJECT UPDATE – CALTRANS AUTHORIZED LIST
9th May 20227:52 amRNSKEY ROLE FOR POZZOLAN IN CEMENT DECARBONISATION
4th May 20227:00 amRNSPROJECT UPDATE – CS NATURAL POZZOLAN
30th Mar 202210:57 amRNSDirector/PDMR Shareholding
8th Mar 20229:12 amRNSUPDATE - CS PROJECT
31st Jan 20223:41 pmRNSExercise of Warrants & TVR
31st Jan 202212:09 pmRNSVoting at AGM
27th Jan 20223:06 pmRNSResult of AGM
18th Jan 202210:00 amRNSARRANGEMENTS FOR 2022 AGM
10th Jan 202212:21 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
17th Dec 202111:00 amRNSANNUAL REPORT & NOTICE OF 2022 AGM
13th Dec 20217:00 amRNSAudited Results for the year to 30 September 2021
10th Nov 20214:41 pmRNSSecond Price Monitoring Extn
10th Nov 20214:35 pmRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSAGREEMENT WITH KINROSS GOLD– JACKSON’S WASH CLAIMS
23rd Aug 20219:53 amRNSBaker's Gold Project - drilling update
17th Aug 20217:00 amRNSUpdate: CS Pozzolan- Perlite Project
29th Jun 20217:00 amRNSBaker’s Project - Drilling Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.